New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review

SIMPLE SUMMARY: In ovarian cancer, about 70% of patients experience relapse despite primary cytoreductive surgery and platinum-based chemotherapy. The occurrence of resistance to chemotherapeutic agents remains a major obstacle in this context. Various factors are involved. The use of immunotherapy...

Descripción completa

Detalles Bibliográficos
Autor principal: Bachmann, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669965/
https://www.ncbi.nlm.nih.gov/pubmed/38001616
http://dx.doi.org/10.3390/cancers15225356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669965/
https://www.ncbi.nlm.nih.gov/pubmed/38001616
http://dx.doi.org/10.3390/cancers15225356

Ejemplares similares